Livewire has acquired Market Index, the country’s leader in free stock market data.
Find out why.

SIR-tainly a good performer..

Wilson Asset Management

Wilson Asset Management

SIR-tainly a good performer... Medical device group Sirtex (ASX: SRX) held its AGM this week. Sirtex's major product is SIR-Sphere - a treatment for liver cancer usually used in the final stages of cancer to prolong life expectancy. The company is currently undergoing trials for SIR-Sphere to be used at an earlier stage of liver cancer upon diagnosis, with results expected mid-2015. At the AGM, comments about the trial underway were positive and dose sales guidance was strong and ahead of market expectations, up 27% over the first four months of the financial year. SRX's share price has more than doubled in the last 12 months and closed up 10.0% this week. We own SRX in the investment portfolio.


Wilson Asset Management

Wilson Asset Management has a track record of making a difference for shareholders and the community for more than 20 years. As the investment manager for eight leading LICs – WAM Capital (ASX: WAM), WAM Leaders (ASX: WLE), WAM Global (ASX: WGB),...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.